Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

453 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tumor mutational load is prognostic for progression to therapy among high-count monoclonal B-cell lymphocytosis (HCMBL).
Kleinstern G, Boddicker NJ, O'Brien DR, Allmer C, Rabe KG, Norman AD, Griffin R, Yan H, Ma T, Call TG, Bruins L, Brown S, Bonolo de Campos C, Hanson CA, Leis JF, Ding W, Vachon CM, Kay NE, Oakes CC, Parker A, Brander DM, Weinberg JB, Furman RR, Shanafelt TD, Cerhan JR, Parikh SA, Braggio E, Slager SL. Kleinstern G, et al. Among authors: hanson ca. Blood Adv. 2024 Feb 15;8(9):2118-29. doi: 10.1182/bloodadvances.2023012242. Online ahead of print. Blood Adv. 2024. PMID: 38359367 Free PMC article.
One thousand patients with essential thrombocythemia: the Mayo Clinic experience.
Gangat N, Karrar O, Al-Kali A, Begna KH, Elliott MA, Wolanskyj-Spinner AP, Pardanani A, Hanson CA, Ketterling RP, Tefferi A. Gangat N, et al. Among authors: hanson ca. Blood Cancer J. 2024 Jan 18;14(1):11. doi: 10.1038/s41408-023-00972-x. Blood Cancer J. 2024. PMID: 38238303 Free PMC article.
Prediction of outcomes for high-count monoclonal B lymphocytosis using an epigenetic and immunogenetic signature.
Abdelbaky SB, Giacopelli B, Rabe KG, Yamaguchi K, Wu YZ, Yan H, Shanafelt TD, Parikh SA, Ding W, Hampel PJ, Brown S, Cerhan JR, Vachon CM, Kay NE, Hanson CA, Parker AS, Braggio E, Slager SL, Oakes CC. Abdelbaky SB, et al. Among authors: hanson ca. Blood. 2024 Apr 25;143(17):1752-1757. doi: 10.1182/blood.2023022180. Blood. 2024. PMID: 38194687 Free article.
A globally applicable "triple A" risk model for essential thrombocythemia based on Age, Absolute neutrophil count, and Absolute lymphocyte count.
Tefferi A, Loscocco GG, Farrukh F, Szuber N, Mannelli F, Pardanani A, Hanson CA, Ketterling RP, De Stefano V, Carobbio A, Barbui T, Guglielmelli P, Gangat N, Vannucchi AM. Tefferi A, et al. Among authors: hanson ca. Am J Hematol. 2023 Dec;98(12):1829-1837. doi: 10.1002/ajh.27079. Epub 2023 Sep 4. Am J Hematol. 2023. PMID: 37665758
Relationship among three common hematological premalignant conditions.
Boddicker NJ, Parikh SA, Norman AD, Rabe KG, Griffin R, Call TG, Robinson DP, Olson JE, Dispenzieri A, Rajkumar V, Kumar S, Kay NE, Hanson CA, Cerhan JR, Murray D, Braggio E, Shanafelt TD, Vachon CM, Slager SL. Boddicker NJ, et al. Among authors: hanson ca. Leukemia. 2023 Aug;37(8):1719-1722. doi: 10.1038/s41375-023-01914-z. Epub 2023 May 5. Leukemia. 2023. PMID: 37147423 Free PMC article. No abstract available.
Predictors of response to venetoclax plus hypomethylating agent therapy and survival in blastphase myeloproliferative neoplasm.
Gangat N, Ilyas R, McCullough K, Begna KH, Al-Kali A, Patnaik MM, Litzow MR, Hogan WJ, Mangaonkar A, Alkhateeb H, Shah MV, Elliott MA, Foran JM, Badar T, Palmer JM, Hanson CA, Pardanani A, Tefferi A. Gangat N, et al. Among authors: hanson ca. Haematologica. 2023 May 1;108(5):1423-1428. doi: 10.3324/haematol.2022.282019. Haematologica. 2023. PMID: 36519330 Free PMC article. No abstract available.
453 results